Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate.

@article{Erdenebaatar2018AdministrationOC,
  title={Administration of Cabergoline Contributes to Preserving Fertility in Young Hyperprolactinemic Patients With Endometrial Cancer Treated With Medroxyprogesterone Acetate.},
  author={Chimeddulam Erdenebaatar and M Yamaguchi and Fumitaka Saito and Mahina Monsur and Ritsuo Honda and Hironori Tashiro and Takashi Ohba and Hidetaka Katabuchi},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2018},
  volume={28 3},
  pages={
          539-544
        }
}
BACKGROUND An association between high levels of serum prolactin and endometrial cancer (EC) has been reported. However, the effect of antiprolactin drugs on hyperprolactinemic patients with EC has not been determined. The aim of this study was to confirm the effect of cabergoline on young hyperprolactinemic patients treated with medroxyprogesterone acetate (MPA) for the preservation of fertility. METHODS A retrospective observational study was conducted to identify patients with atypical… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.

Serum Prolactin Contributes to Enhancing Prolactin Receptor and pJAK2 in Type I Endometrial Cancer Cells in Young Women Without Insulin Resistance.

  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2019
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2002
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms

F Saito, H Tashiro, YamaguchiM
  • Gynecol Endocrinol
  • 2016
VIEW 1 EXCERPT